NASDAQ:BNGO

Bionano Genomics Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy BNGO

*Your capital is at risk

$1.30

+0.0400 (+3.17%)

At Close: Jun 03, 2026

BioNano Genomics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.39. In total, the insiders bought 714.87K and sold 14.6K BNGO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	99.39
● Buy	714.87K shares
● Sell	14.6K shares
61% Buy Activity Strong Positive Correlation
Buy Signal High Confidence May 14, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 99.39. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 14, 2025 Sell	Common Stock F-InKind	Holmlin R. Erik President And CEO	CEO / President	198 Value: $687
Mar 14, 2025 Buy	Stock Option (Right to Buy) A-Award	Oldakowski Mark Chief Operating Officer	C-Suite Officer	6 966 Value: $24.2K
Mar 14, 2025 Buy	Stock Option (Right to Buy) A-Award	Chaubey Alka Chief Medical Officer	Officer	6 966 Value: $24.2K
Mar 14, 2025 Buy	Stock Option (Right to Buy) A-Award	Chaubey Alka Chief Medical Officer	Officer	6 966 Value: $24.2K
Mar 14, 2025 Buy	Stock Option (Right to Buy) A-Award	Oldakowski Mark Chief Operating Officer	C-Suite Officer	6 966 Value: $24.2K
Mar 14, 2025 Sell	Common Stock F-InKind	Holmlin R. Erik President And CEO	CEO / President	198 Value: $687
Mar 14, 2025 Buy	Stock Option (Right to Buy) A-Award	Holmlin R. Erik President And CEO	CEO / President	17 449 Value: $60.5K
Mar 14, 2025 Buy	Stock Option (Right to Buy) A-Award	Adamchak Mark Principal Accounting Officer	Officer	3 029 Value: $10.5K
Mar 14, 2025 Buy	Stock Option (Right to Buy) A-Award	Dixon Jonathan V. General Counsel	Officer	6 559 Value: $22.8K
Feb 15, 2025 Sell	Common Stock F-InKind	Oldakowski Mark Chief Operating Officer	C-Suite Officer	20 Value: $115
Feb 15, 2025 Sell	Common Stock F-InKind	Dixon Jonathan V. General Counsel	Officer	6 Value: $34
Feb 15, 2025 Sell	Common Stock F-InKind	Holmlin R. Erik President And CEO	CEO / President	51 Value: $292
Feb 15, 2025 Sell	Common Stock F-InKind	Chaubey Alka Chief Medical Officer	Officer	18 Value: $103
Feb 15, 2025 Sell	Common Stock F-InKind	Adamchak Mark Principal Accounting Officer	Officer	4 Value: $23
Feb 15, 2025 Sell	Common Stock F-InKind	Adamchak Mark Principal Accounting Officer	Officer	4 Value: $23
Feb 15, 2025 Sell	Common Stock F-InKind	Chaubey Alka Chief Medical Officer	Officer	18 Value: $103
Feb 15, 2025 Sell	Common Stock F-InKind	Holmlin R. Erik President And CEO	CEO / President	51 Value: $292
Feb 15, 2025 Sell	Common Stock F-InKind	Dixon Jonathan V. General Counsel	Officer	6 Value: $34
Feb 15, 2025 Sell	Common Stock F-InKind	Oldakowski Mark Chief Operating Officer	C-Suite Officer	20 Value: $115
Oct 01, 2024 Buy	Stock Option (Right to Buy) A-Award	Adamchak Mark Principal Accounting Officer	Officer	17 500 Value: $7K
Oct 01, 2024 Buy	Stock Option (Right to Buy) A-Award	Adamchak Mark Principal Accounting Officer	Officer	17 500 Value: $7K
Sep 18, 2024 Buy	Common Stock	Adamchak Mark Principal Accounting Officer	Officer	0 Value: $0
Sep 18, 2024 Buy	Stock Option (Right to Buy)	Adamchak Mark Principal Accounting Officer	Officer	1 200 Value: $93.2K
Sep 18, 2024 Buy	Stock Option (Right to Buy)	Adamchak Mark Principal Accounting Officer	Officer	584 Value: $24.8K
Sep 18, 2024 Buy	Stock Option (Right to Buy)	Adamchak Mark Principal Accounting Officer	Officer	753 Value: $8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BIONANO GENOMICS INC.

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents ...

Read Full Profile Here